2020: Annus Horribilis, The Worst Is Yet to Come? Poverty, Unemployment, Despair
By Stephen Lendman | January 1, 2021
For most Americans, 2020 was disastrous for their safety, well-being and future.
Unprecedented numbers of people lost jobs — a greater percent of working-age Americans than in the 1930s Great Depression.
Millions more became way underemployed earning poverty wages with few or no benefits — struggling daily to survive.
Well over 100,000 small businesses went bankrupt or otherwise shut down permanently because of draconian lockdowns, quarantines and related policies.
According to Gallup survey data, “Americans’ mental health ratings s(ank) to a new low” in 2020 — with no end to mass-misery in prospect.
Chicago’s Water Tower Place is the city’s preeminent downtown shopping mall along its Magnificent Mile.
Its survival is threatened by lack of enough retail traffic.
A city news report said there’s “real anxiety that Chicago’s main shopping districts — the Magnificent Mile and Gold Coast — are (at risk) of falling apart” for lack of enough revenue to keep operating.
The Illinois Retail Merchants Association said “economic fallout” from what’s going on “made it difficult for businesses to keep up with high downtown rents.”
What’s true about Chicago’s retail environment applies to the US nationwide — with no end of it in prospect looking ahead.
According to the National Restaurant Association, up to half of the nation’s restaurants may close permanently if the current environment continues or worsens — millions of jobs to be lost with them.
Looking ahead in the new year, is unprecedented food insecurity, hunger, malnutrition, untreated illnesses, and homelessness coming in the weeks and months ahead?
While Congress and the Wall Street owned and controlled Fed throw trillions of dollars of free money at the nation’s privileged class, most US households never endured harder than ever hard times than now.
They’re worsening, not improving, because of indifference in high places toward the nation’s most disadvantaged that are exploding in numbers of affected millions of people — the US middle class disappearing in plain sight.
Everything going on — the Greatest Main Street Depression in US history — was planned by US dark forces in cahoots with monied interests.
It’s all about benefitting them exclusively by exploiting most others.
It includes creating an unprecedented in size permanent underclass.
Longer-term, the diabolical scheme aims to create a ruler-serf society, harming the vast majority of Americans.
Seasonal flu/influenza — disguised as covid — has been and continues to be the phony pretext for getting Americans to go along with what no one should tolerate.
Their fundamental freedoms may be permanently lost so privileged interests can more greatly benefit from their misery.
Providing $600 stimulus checks to qualified households pales in comparison to open-checkbook handouts to Wall Street, other corporate favorites, and the already super-rich.
The paltry amount mocks growing poverty and deprivation that’s highly likely to worsen in the new year.
The US is not only unsafe and unfit to live in, it’s permanently thirdworldized.
It’s a totalitarian/plutocratic banana republic in the Northern Hemisphere — the world’s largest and most threatening to everyone everywhere.
On New Year’s Day, establishment media maintained their mass deception drumbeat.
According to NYT fake news, “in 2021 things will start getting better (sic).”
“And there’s good reason to believe that once the good news starts, the improvement in our condition will be much faster and continue much longer than many people expect (sic).”
The Washington Post pretended that “the big story of 2021 could be a very hopeful one (sic).”
Like other establishment media, it’s pushing the myth of mass-vaxxing to the rescue — ignoring how experimental covid vaccines may cause irreparable harm to human health overall, along with risking the illness they’re supposed to protect against but won’t.
According to the Wall Street Journal, “(t)he great comeback of 2021 is surely coming (sic).”
“(I)t will begin to explode in late spring, with vaccines more available and a spreading sense that things are easing off, and be fully anarchic by summer (sic).”
The above disinformation ignores the reality of unprecedented/made-in-the USA misery that’s highly likely to worsen ahead and become permanent for most Americans.
I see nothing to be optimistic about in the new year and what follows.
The only solution is popular revolution. Nothing else can prevent state-sponsored dystopia that’s well underway.
It’ll worsen without mass outrage and rebellion against the diabolical system.
It’s our lives, our well-being, our future, and our choice to accept the unacceptable or rise up against it.
Navalny and Handlers Lose the Plot… He Is a Convicted Felon on Probation
By Finian Cunningham | Strategic Culture Foundation | January 2, 2021
Russia’s federal prison authorities were right to jolt Alexei Navalny this week by warning him to return immediately from Germany or else face a suspended sentence being made into jail time.
The “professional” opposition activist claims to be convalescing in Germany after he was allegedly poisoned by a Soviet-era nerve agent in August. Western news media dutifully repeat the claim that Navalny is “recuperating” in Germany after having survived an assassination plot by Kremlin agents. Navalny has personally accused Russia’s President Vladimir Putin of ordering the alleged hit.
Last week, a team of medics from the Berlin hospital where Navalny had been staying published a paper in The Lancet medical journal in which they claimed he had been poisoned with Novichok nerve agent. Their findings are dubious because the medics acknowledged the involvement of German military intelligence laboratories in conducting their analysis.
But one thing the German doctors did let slip was that a 55-day follow-up check on Navalny ascertained that he had made a “near-complete recovery”.
The Russian dissident figure was flown to Berlin on August 22, two days after he was treated in a hospital in Omsk, Russia. Thus, the German medical team are indicating – no doubt inadvertently – that Navalny’s health recovered nearly two months ago, if not before that.
That means there is no medical reason why he should remain at large in Germany. His claims of “convalescing” and the Western media’s indulgence of those claims are false, if the German doctors are correct about his “recovery”.
Despite Navalny’s arrogant disdain for Russian state laws, he is nevertheless answerable to those authorities as a citizen. While in Germany he was on probation for a suspended jail sentence concerning a fraud conviction in 2014. His so-called Anti-Corruption Foundation (FBK) has a checkered history of shady financing, from allegations of foreign funding by the U.S. State Department to charges of embezzling millions of dollars. Ironically, the blogger and media activist produces slick programs accusing the Russian government of corruption.
In any case, under the laws of the Russian Federation, the 44-year-old Navalny was on probation during the past four months of his stay in Germany. For the last two months, he is in good health, according to his German doctors. So there are no grounds for why he should abscond from Russian territory and evade the laws for which he is answerable.
Not only is Navalny living as if he above the law, he has also shown flagrant contempt for the Russian authorities.
Last week, he published a video on his website claiming that he had pranked a named member of Russia’s security service, the FSB, into admitting that agents had poisoned him while he was visiting the Siberian city of Tomsk on August 20. He was later flown in an emergency to Omsk where he was treated after having apparently fallen ill onboard a flight to Moscow.
The FSB dismissed Navalny’s prank telephone claim as a “deep fake”. The Russian doctors who treated him in Omsk – and who probably saved his life – have repeatedly stated that their tests showed there was no poison in Navalny’s body, and specifically no traces of nerve agent. They said his illness was due to a metabolic disorder. Perhaps self-induced as a ruse to later transfer to Germany?
The transcript of Navalny’s purported prank call to the FSB agent reads like a comic set-up. Posing as a senior member of Russia’s national security council, Navalny affects to bully the supposed agent as if he is a pathetic stooge.
A telling segment is where the self-styled super sleuth fishes for compliments about his own character from the purported FSB man, betraying the narcissism of a megalomaniac.
Again, incredibly, we are expected to believe that someone who had a near-death experience with a lethal nerve poison and who is “convalescing” still in Germany somehow managed to find the energy and mental reserves to pull off a daring 45-minute telephone sting.
If Navalny is fit enough to participate in such practical jokes – regardless of their credibility – then he is surely fit enough to abide by Russian laws and respect his probation terms. As the Russian Federal Prison Service stated this week: “The convicted man is not fulfilling all of the obligations placed on him by the court, and is evading the supervision of the Criminal Inspectorate.”
One gets the unerring impression that Navalny and his foreign handlers have become so self-intoxicated with hubris that they are blind to their own absurd implausibilities.
Why was he permitted to fly by air ambulance to Berlin in the first place if the Russian authorities had evil designs against him?
While there, as a guest of the German government, Navalny has wildly accused President Putin of ordering his alleged assassination. The European governments have subsequently and rashly imposed sanctions on Russia in support of Navalny’s unfounded claims. Then we have the media activist mounting further provocations parlayed into even more outlandish accusations against President Putin and the Kremlin.
All the while there has been no evidence of poisoning presented to support these claims, other than unverifiable assertions by German doctors working with German military intelligence labs, as well as two other NATO laboratories and the Organization for the Prohibition on Chemical Weapons. All of them including the OPCW (the latter compromised over complicity in NATO false-flag provocations in Syria) have refused to share their analytical data and samples with Russia, and yet they are demanding that Moscow launch a criminal investigation into the Navalny case.
The abdication by European governments of due process and of respect for Russian state laws, its government, and its president is astounding. They are indulging a foreign-sponsored gadfly as if he is the sovereign representative of the Russian Federation.
Navalny and his foreign allies have lost the plot in their own telling of an alleged assassination plot.
First things first: he is a convicted felon who is answerable to Russian law. Pushing false flags and slanderous falsehoods from abroad with the intent of damaging Russia’s sovereignty is an abuse of his rights.
Arrogant and overindulged Navalny is patently incapable of even understanding his obligations under law as a Russian citizen. He evidently feels above the law, like many of his Western backers. That’s why Russia is right to tell him to put up or shut up.
The criminal WHO blows its own cover: fake PCR test
By Jon Rappoport | December 31, 2020
In early 2020, the WHO accepted a PCR test for “SARS-CoV-2” that was designed without having possession of the virus. Yet the test is meant to detect… the missing virus. This is evidence of deep criminal intent. [1]
But as of December 14, 2020, WHO has made a correction [2]. Thereby blowing its own cover. Why?
Two reasons. Huge numbers of people have caught on to the PCR test scam. And by their correction, WHO paves the way for “declining COVID case numbers”—thereby making it appear the new vaccine is a roaring success. I predicted this development. [3] [4]
A brief review. The PCR test (a complete fraud for several reasons) is run in “cycles.” Each cycle is a giant magnification of a tiny portion of the swab sample taken from the patient.
As I’ve reported, even Tony Fauci readily asserts that if the PCR is run at 35 cycles or higher, it’s meaningless. [5] [6]
Every positive result—indicating “infection with the virus”—occurring at 35 cycles or higher is meaningless.
BUT, as I’ve also pointed out, public health agencies recommend running the PCR test at up to 40 cycles. Therefore, labs comply.
Therefore, millions upon millions of PCR tests results, over the last nine months, which indicate “infection,” are a vast lie.
Therefore, the COVID case numbers are a vast lie, and the lockdowns, which are based on those numbers, are absurd, insane, criminal, and predatory.
NOW, the WHO is walking back their stance on how the PCR should be run, for the reasons I mentioned above.
The WHO document is titled, “WHO Information Notice for IVD Users/Nucleic acid testing (NAT) technologies that use real-time polymerase chain reaction (RT-PCR) for detection of SARS-CoV-2.” [2]
Here are the money quotes. The language is mealy-mouthed, intentionally confusing, cautious, and sterile. Nevertheless, we can see the intent to lower the number of test cycles.
“Users of RT-PCR reagents should read the IFU [Information for Use] carefully to determine if manual adjustment of the PCR positivity threshold is necessary to account for any background noise which may lead to a specimen with a high cycle threshold (Ct) value result being interpreted as a positive result.”
Translation: Using too many test cycles—aka “high cycle threshold (Ct) value”—has resulted in patients being told they’re infected, which is a lie.
“In some cases, the IFU will state that the cut-off should be manually adjusted to ensure that specimens with high Ct values are not incorrectly assigned SARS-CoV-2 detected due to background noise.”
Translation: Running the test with a high number of cycles yields “background noise”—aka a false positive result. The patient is told he’s infected but he’s not.
“The design principle of RT-PCR means that for patients with high levels of circulating virus (viral load), relatively few cycles will be needed to detect virus and so the Ct value will be low. Conversely, when specimens return a high Ct value, it means that many cycles were required to detect virus. In some circumstances, the distinction between background noise and actual presence of the target virus is difficult to ascertain.”
Translation: When the test is run with a high number of cycles, we can’t tell the difference between “irrelevant” and “meaningful.”
A frank and honest translation of the WHO message: “We’re changing the way we’re doing PCR tests. We were running them with a high number of cycles and getting millions of false positives, and those numbers were deployed to justify the lockdowns—but NOW we’re moving to a lower number of cycles. This change, all on its own, will result in fewer positive results, fewer case numbers, making the vaccine look VERY GOOD.”
The WHO is still crazy, still criminal, but not entirely stupid. They know what they’re doing and why.
SOURCES:
[1] https://blog.nomorefakenews.com/2020/12/25/you-thought-the-pcr-test-detects-an-actual-virus-wrong/
[2] https://www.who.int/news/item/14-12-2020-who-information-notice-for-ivd-users
[4] https://blog.nomorefakenews.com/2020/11/13/how-theyll-fake-the-success-of-the-covid-vaccine/
[6] https://blog.nomorefakenews.com/2020/12/08/florida-forces-labs-to-report-number-of-pcr-test-cycles/
10 Facts From the UK Government Pfizer Vaccine Guidance that Promote “Vaccine Hesitancy”
By Johnny Vedmore |
Unlimited Hangout| December 29, 2020
Official government guidance has been released in the United Kingdom to assist healthcare professionals in administering the Pfizer/BioNTech vaccine BNT162b2. While the UK government goes to war against supposed misinformation, the official narrative is clearly based on very little to no supporting data from incomplete clinical trials. This article examines the document “Reg 174 Information for UK Healthcare Professionals” and narratives being pushed in the mainstream media that directly contradict that document.
Healthcare professionals globally have begun the controversial campaign to vaccinate large swathes of their respective populations with various experimental medical products. The vanguard of the mainstream pro-vax extremists have been busy enacting mass censorship tactics and committing blatant acts of digital book burning on a scale never before seen in the internet era. So-called “trusted sources” have become indistinguishable from the state-run media apparatus of your bog-standard dictatorship with the usual MSM outlets working non-stop to skew any information that threatens their hyper-aggressive official narrative. Throughout 2020, our basic civil liberties have been quickly stripped away by countless unelected officials from a wide array of unaccountable global power structures, all of them connected to a small group of elites who are sitting aloft the COVID-19 money train and using the heavily exaggerated epidemic to achieve their own long term goals.
Any useful data, scientific paper, or other credible research contradicting the official narrative is being purposely hidden from view. Too many uncomfortable, yet ultimately necessary, questions for vaccine companies such as Moderna, AstraZeneca, Pfizer, and their many collaborators, are being heavily censored by those pushing their own various COVID-related agendas. The promised “war on truth” is in full swing throughout all nations globally and their respective state media machines are nearly all towing their official government lines. Mainstream talk shows and podcasts worldwide are also in lockstep, and have often been caught publicly guilt-tripping their easily swayed audiences to help push them deeper into queues for mass medical trials for vaccines and other products that lack research studies on their long term effects. This inconvenient lack of completed research will not stop the money men from pumping this milky white liquid into the arms of hundreds of millions of people worldwide.
At this point in the process, the medical professionals who are administering these heavily rushed vaccines are being given the opportunity to defer responsibility and accountability for their actions to the government’s vaccine-related guidance. As the Stanley Milgram experiments have proven, when the option to defer responsibility is present, then roughly 65% of participants will follow the orders they have received regardless of the risk to their subjects. In 1974, Stanley Milgram detailed the behaviour of his participants in his famous study and suggested that people have two basic states of behaviour when they are in a social situation: “The autonomous state”, where people direct their own actions and ultimately take responsibility for the results of those actions and “the agentic state”, where people allow others to direct their actions and then pass off the responsibility for the consequences to the person giving orders, in essence acting as agents of another person’s will.
The majority of the people who are injecting these experimental drugs into their trusting patients are not likely to question the official guidance, as the overwhelming majority will often simply be in an agentic state. Thus, it should be in the best interest of anyone thinking of receiving an mRNA vaccine to first study the guidance offered by the various government sources. And, when one does study the official guidance given to healthcare professionals, one will find many different glaring contradictions and shocking admissions.
While all official bodies are attacking any inconvenient fact as misinformation, they are all busy defrauding the global population with their own misinformation campaigns that surely would have inspired awe in the likes of Joseph Stalin. So, let’s study their own words and examine the NHS guidance given to the medical professionals in the UK for the administration of the recently approved Pfizer-BioNTech vaccine.
An Introduction to Reg 174 Information for UK Healthcare Professionals (#1-4)
The short ten page official guidance being given to UK healthcare professionals contains many interesting admissions. In fact, the document, released in early December 2020 to accompany the vaccine rollout, appears to advise healthcare practitioners not to risk giving the experimental injection to the majority of the people who are due to receive the vaccine, particularly “prioritized” populations. Those in charge are pushing to vaccinate as much of the population as possible, before any critical public questions can be asked and answered, a situation that has left the safety and ethics of the vaccination campaign questionable at best and inhumane at worst.
In going through the Reg 174 document, it becomes very clear that there are many issues and recommendations that are being hidden from the general public. Here are ten of the most notable causes for concern contained within the official UK guidance document.
The authorisation to produce and supply this experimental vaccine in the UK was given by the UK Department of Health and Social Care, led by Matt Hancock – the UK Secretary of Health, and also by the Medicines & Healthcare products Regulatory Agency (MHRA). While the MHRA is part funded by the Department of Health and Social Care for the regulation of medical devices, the costs of medicine regulations are met through fees paid by the pharmaceutical industry. The agency’s financial reliance on Big Pharma has led to suggestions by some Members of the UK Parliament that the MHRA is not actually independent. Being in associated roles at the MHRA since 1985, June Raine was officially appointed as CEO in September 2019 and had previously been the Director of Vigilance and Risk Management in the Medicines Division.
2. The official Phase III safety trials will not be completed until 2023
Section 1 of the medical guidance clearly states that this vaccine guidance refers specifically to the “Pfizer/BioNTech COVID-19 mRNA Vaccine BNT162b2 concentrate for solution for injection.” On 2 December 2020, the MHRA became the first medicines regulator in history to approve an mRNA vaccine for human use, granting emergency authorisation for BioNTech and Pfizer’s BNT162b2 COVID-19 vaccine for widespread use only a week after its first Phase III eight-week trial had finished. However, the Phase III trials for BNT162b2 will not actually be fully completed until January 2023 meaning that, if you’re ready to take the vaccine now, then you should be informed that the safety trials for these experimental vaccines have at least two more years before the results are in. Regardless of that fact, Raine told reporters “no corners have been cut in approving it” and that “the benefits outweigh any risk”.
3. Will you be truly “protected” from COVID-19?
The official guidance clearly states that individuals may not be protected until at least 7 days after their second dose of the vaccine. This fact has again been ignored by various reckless pro-vax media campaigns where powerful elites such as Tony Blair have contradicted this specific recommendation, suggesting recently in an interview that people should only be given a single dose of any vaccine. Mr Blair told BBC Radio 4’s Today programme that “Does the first dose give you substantial immunity, and by that I mean over 50 percent effectiveness? If it does, there is a very strong case for not, as it were, holding back doses of the vaccine.” Blair, writing in the Independent, stated that the current vaccination strategy needed to be “altered and radically accelerated”. In responding to Blair’s call for radical acceleration, Professor Wendy Barclay, chair of virology at Imperial College London and member of the UK government’s NERVTAG, said: “I think that the issue with [Mr Blair’s suggestion] is that the vaccine is on the basis of being given in two doses, and the efficacy is on that basis.” Barclay went on to point out that “To change at that point, one would have to see a lot more analysis coming out from perhaps the clinical trial data.”
It is very important to pay attention to the wording of Reg 174 because the Pfizer vaccine purportedly boosts the immune system, rather than stopping the transmission of the virus. This would suggest that you will not be fully “protected” from COVID-19 and that you will still be able to catch the virus and could still suffer complications. The official guidance also states that “Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the vaccine,” with the guidance admitting “No data are available about concomitant use of Immunosuppressants.”
Reg 174 goes on to make this most pertinent of points when it states “As with any vaccine, vaccination with COVID-19 mRNA Vaccine BNT162b2 may not protect all vaccine recipients.” The guidance also states clearly that “administration of COVID-19 mRNA Vaccine BNT162b2 should be postponed in individuals suffering from acute severe febrile illness and that individuals receiving anticoagulant therapy or those with a bleeding disorder that would contraindicate intramuscular injection, should not be given the vaccine unless the potential benefit clearly outweighs the risk.”
4. The complicated multistage dilution and thawing process of the vaccine vials opens the major possibility of human error
In investigating the official instructions for the vaccine’s administration, we can clearly see that there are plenty of opportunities for potential human error. Section 2 of this document describes the distributed vaccine as coming in “a multidose vial and must be diluted before use.” Confirming that each vial contains 0.45 ml (which equates to 5 doses of 30 micrograms) of BNT162b2 RNA embedded in lipid nanoparticles. The delicate preparation process will be repeated 100s of millions of times globally and the multidose vial will be stored frozen and must be thawed prior to dilution. The guidance describes the process for preparing the frozen vials stating that they should be transferred to temperatures of between 2 °C to 8 °C to thaw or, alternatively, the frozen vials may also be thawed for 30 minutes at temperatures up to 25 °C for immediate use. Once thawed, the undiluted vaccine can be stored for up to 5 days at 2 °C to 8 °C, and up to 2 hours at temperatures up to 25 °C. The thawed vial must then come to room temperature and be gently inverted 10 times prior to dilution.
Some of the featured diagrams and instructions found in Reg 174
The complicated thawing and dilution process will obviously leave room for individual error. Healthcare practitioners are also warned not to shake the vials and instead to gently turn them 10 times. Prior to dilution, the vaccine should present as an off-white solution with no particulates visible. The guidance states that you must discard the vaccine if particulates or discolouration are present. The thawed vaccine must be diluted in its original vial with 1.8 mL sodium chloride 9 mg/mL (0.9%) solution for injection, using a 21 gauge or narrower needle and aseptic techniques and this complex, multistage process isn’t completed there.
The healthcare professional should then equalise vial pressure before removing the needle from the vial by withdrawing 1.8 mL of air into the empty diluent syringe. Then they should gently invert the diluted solution 10 times, again being careful not to shake the solution. The official guidance continues: “The diluted vials should be marked with the dilution date and time and stored between 2 °C to 25 °C. After dilution, the vial contains 5 doses of 0.3 mL.” The healthcare professionals are then told to “withdraw the required 0.3 mL dose of diluted vaccine using a sterile needle and syringe and discard any unused vaccine within 6 hours after dilution.”
The instructions must be followed precisely to safely administer the mRNA vaccine; there are no data available on potential consequences for the vaccine recipient if anything goes wrong during this tedious and complex multistage process. On 19 December 2020, video emerged of an official drive-thru vaccination hub which had begun operating out of a car park of Hyde Leisure Centre in Greater Manchester. The video in question, shared by No Comment TV on YouTube, shows people being vaccinated outdoors at Hyde Leisure Centre by gloveless staff and in less than sterile conditions. In an article in the Manchester Evening News four days prior to the videos release the local news site stated that “The first batch of the Pfizer/BioNTech vaccine arrives in the borough on Tuesday, with vaccinations starting at Hyde Leisure Centre on Wednesday, December 15.”
No Data Available (#5-10)
When reading Reg 174, you will soon notice a recurring theme throughout the document. The guidance clearly states on multiple occasions that there are no data available concerning some of the most important questions surrounding the mRNA vaccine. As previously noted, the actual Phase III section of the safety trials will not be completed until January 2023, meaning that two years of trials are still to be run before the vaccine can be confirmed as safe, effective and ethical.
5. The safety and efficacy of COVID-19 mRNA Vaccine BNT162b2 in children under 16 years of age have not yet been established
Although the guidance states that the safety and efficacy of the COVID-19 vaccine has not been established in children, it doesn’t mean that children have not been included within the studies. In fact, in the official Pfizer study entitled “Protocol C4591001”, one of the two main study groups included children as young as 12 years old. The inclusion of children in trials but not the guidance raises the important question, why were children included in the trial? If the vaccine is not to be given to those under the age of 16 years old, then why include children as young as 12 in the trials for an experimental vaccine technology never before authorised for use in humans?
The mainstream media, instead of raising concerns about the involvement of children in the Pfizer clinical trials, have been fully supportive of the move to test experimental pharmaceuticals on minors. CNN reported on children as young as 12 being involved in trials in an October 2020 article entitled “This 12-year-old is happy to be testing a Covid-19 vaccine” while Microsoft News recently announced that “China begins Covid test trials on children as young as age three.”
6. No data are available on the use of COVID-19 mRNA Vaccine BNT162b2 in persons that have previously received a full or partial vaccine series with another COVID-19 vaccine
We are currently witnessing the very first of many tailor-made vaccines being rolled out for general use, so don’t expect the COVID-19 jabs to be the only vaccines coming our way. With a 20 to 1 return on investment on many of these new technologies, most pharmaceutical giants will surely be lobbying governments across the globe for the next “necessary” vaccination program. The idea of multiple COVID-19 vaccinations throughout the year is already being presented as a very possible outcome for the future of humanity. Yet, no studies have been completed showing the risk of taking different types of vaccines. There have also been suggestions that people will have to have the same vaccine that they had previously taken every six months or so. This will leave Astrazeneca, Pfizer and Moderna picking up repeat vaccine contracts worth billions in secured future revenue before there are any real data on the results of the vaccines.
7. No interaction studies have been performed and there are no, or a limited amount of, data from the use of COVID-19 mRNA Vaccine BNT162b2
Admissions like these should be a cause for concern for anybody reading the official guidance. While officials and carefully chosen “trusted sources” are telling you that “no corners have been cut” in the race to approve these vaccines, it is also true that no full length studies have been completed either. These two facts are juxtaposed and obviously contradict the official narrative that is being thrust upon the general public by all of those involved.
It is clear that the officials have no real data on what will happen next and that there is a tsunami of ethical questions that are not being answered. In the absence of data, there will be speculation.
8. It is unknown whether COVID-19 mRNA Vaccine BNT162b2 is excreted in human milk and It is unknown whether COVID-19 mRNA Vaccine BNT162b2 has an impact on fertility
It is vital to note the potential dangers posed by the BNT162b2 to unborn and newborn babies as well as the reproductive organs in general. There are so many parts of the Pfizer/BioNTech clinical trials that have not yet been completed. Dr. Peter Klatsky, the Director of Fertility Preservation at the Bay Area’s Spring Fertility, talking about the coming animal trials which are to be performed over the coming months was quoted in SFGate as saying, “It will reassure me an awful lot if the protein expression is not seen on the placenta. That the mRNA isn’t making it to the placenta in animals,” he said. “I don’t expect to see any.” The article goes on to explain that it will be about another 9 months until the data has been collected and analyzed.
Section 4.6 of the official guidance recommends pregnant women should not recieve the BNT162b2 vaccine
Big names in mainstream media have also been caught recklessly promoting the vaccine to pregnant women, such as Karen Weintraub writing for USA Today, whose recent article quickly states, “Although there are very little data on how pregnant and nursing mothers will respond to a COVID-19 vaccine, professional organizations and individual doctors say the benefits are very likely to outweigh the risks.” Even though the clinical trials intentionally excluded pregnant women, Weintraub went on to state that “23 women in the Pfizer-BioNTech trial and 13 in Moderna’s became pregnant during the trial.”
While the UK’s official guidance is left sounding ambiguous, on the European continent, the European Medicines Agency (EMA) states that “the Pfizer vaccine should be considered on a case by case basis for pregnant women”, but they also reserve the right to alter the guidance if more data becomes available. It seems there is no longer any erring on the side of caution with some regulators when it comes to the COVID-19 vaccinations.
9. Non-clinical data reveal no special hazard for humans based on a conventional study of repeat dose toxicity but animal studies into potential toxicity to reproduction and development have not been completed
Animal studies have not been completed and, as referred to in the previous section, the data on those animal trials will not be available for another 9 months. It is, of course, a very rare decision to approve an experimental medical technology before any animal studies have been completed. This should be a great cause for concern for any free thinking man or woman. The fact that they have had to use what they refer to as “non-clinical” data in these studies is also in conflict with the idea that the trials were conducted to the highest professional standard. The document also fails to clearly define what non-clinical data actually means.
10. In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products
Possibly the most fascinating admission in the entire document is the absence of any compatibility studies when somebody is given the vaccine while on any other medication or medical treatment. The guidance clearly states “this medicinal product should not be mixed with other medical products.” This completely jaw dropping sentence will lead many to assume that if you are on any medication at all, then you shouldn’t be given the vaccine. Whether this refers to the mixing of other medical properties directly together with the vaccine, or simultaneous dosing of any other medical product is unclear from the official guidance.
The Mail Online and The Guardian reported in 2019 that a staggering 1 in 4 people in England – nearly 12 million people – were taking what was described as “addictive” prescription medicines such as antidepressants, sleeping pills and opioid painkillers, saying that “the NHS must take action”. Those statistics throw into question the mass rollout of a vaccination with no compatability studies. This makes the fact that elderly care home residents, followed by those aged over 80, will be the first to recieve the experimental Pfizer vaccine an extremely risky strategy. Also in 2019, Age UK reported that nearly 2 million older people were on more that 7 prescription medicines and were at “risk of side effects that are severe in some cases, and occasionally even life threatening.” This worrying issue has been barely reported by the “trusted news sources”.
A Conclusive Lack of Real Data
After examining the official guidance, one fact becomes glaringly obvious — there is little to no data on the official Pfizer vaccine in key areas. In the clinical trials, children as young as 12 years old were used as unnecessary guinea pigs. There also wasn’t enough care taken to avoid pregnant women being involved in the initial clinical trials and under the cover of unyielding and uneducated mainstream propaganda, the safety of some of the most vulnerable people involved in the vaccine trials have been ignored by Pfizer and the politicians who have successfully pushed for the public vaccination campaign to essentially replace mass clinical trials. The stage has been set for a potential disaster on an unimaginable scale. It isn’t only the participants of the trials who are risking their health for the sake of big pharmaceutical companies’ hyperinflated profit margin, but it is also the medical professionals who could be risking their futures by collaborating in these risky experimental trials, which will certainly see many people dead and irreversibly injured.
In one section of Reg 174, the Big Pharma giant lays out the risk to people’s health from the Pfizer/BioNTech vaccine. The most common adverse reaction in participants 16 years of age and older was pain at the injection site, which affected a massive 80% of those taking part in the Pfizer trials. Fatigue came a close second with 60% of trial participants becoming sluggish and tired. Half of those involved in the studies suffered from a headache as the experimental vaccine went to work while myalgia was experienced by 30% of vaccine recipients, though the results do not indicate whether the myalgia was acute (short-term) or chronic (long-term). Almost a third of participants came down with chills, while just under 1 in 5 people suffered from arthralgia (joint pain) and 1 in 10 from pyrexia (increased body temperature).
Adverse reactions reported in clinical trials are listed in the study in decreasing order of frequency and seriousness. Just under 1 in 10 people who take the vaccine will suffer from the very common and common adverse reactions referred to in the latter paragraph, such as headaches, myalgia and chills, but the more serious issues are classified as uncommon – including Lymphadenopathy (which causes swollen or enlarged lymph nodes) and nervous system disorders – which may affect up to 1 in 100 people. Rare adverse reactions that could affect up to 1 in 1000 people and very rare adverse reactions that would affect less than 1 in 10,000 of the vaccine recipients were not included in Pfizer’s self-reported safety information. It has obviously been decided that this information should be kept out of the public domain as much as possible to avoid any further vaccine hesitancy.
Not only does the official guidance actively hide the types of rare and very rare adverse effects, but they have also been leaving out some of the adverse reactions reported during the clinical trials. As I write this, the Reg 174 guidance for healthcare professionals is on version 10.1 of the document and, since its release, they have yet to admit to the potential of a certain uncommon adverse reaction to the vaccine being a specific nervous system disorder. Structural nervous system disorders include brain or spinal cord injury, Bell’s palsy, cervical spondylosis, carpal tunnel syndrome, brain or spinal cord tumors, peripheral neuropathy, and Guillain-Barré syndrome. However, previous versions of the guidance gives no clue as to what type of nervous system disorders they were referring to. However, recent articles in the USA Today, heavily promoted by the Microsoft Network, suggested that the Bell’s palsy some people came down with in the vaccine trials wasn’t related to the Pfizer jab. The article states that on Dec. 10, the FDA’s Center for Biologics Evaluation and Research held the 162nd meeting of the Vaccines and Related Biological Products Advisory Committee to discuss the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine. The USA Today piece even goes on to admit that , “a 53-page briefing noted that there had been four cases of Bell’s palsy among the vaccinated group and none among the placebo group.”
Bell’s palsy causes drooping facial muscles similar to the effects of a stroke, image source PTHealth.com
Even though Miriam Fauzia, who wrote the USA Today piece, claims that the Bell’s palsy was not related to the experimental Pfizer vaccine, the 53-page briefing she sources clearly states, “Among non-serious unsolicited adverse events, there was a numerical imbalance of four cases of Bell’s palsy in the vaccine group compared with no cases in the placebo group, though the four cases in the vaccine group do not represent a frequency above that expected in the general population.” While it is true that 1 to 4 people in 10,000 will develop Bell’s palsy within the general population, it should be noted that the 4 cases in the vaccine trials and none in the placebo group makes for a statistical anomoly that must be examined more thoroughly. Instead, the mainstream media moved quickly to discredit the Bell’s palsy links to the Pfizer vaccine using various misleading tactics to achieve their aims.
Many mainstream outlets were caught spouting the same misleading information with articles entitled “Why you shouldn’t worry about a connection between Bell’s palsy and COVID-19 vaccines,” from Business Insider and a Reuters article from 14 December 2020 entitled, “Fact check: Photo does not show three recipients of Pfizer’s COVID-19 vaccine that developed Bell’s palsy.”
In the case of the Reuters article, which is described as written by “Reuters Staff” rather than a specific journalist, the focus was not on the four Pfizer clinical trial participants who developed Bell’s palsy but instead the article discredits a random post on social media of three people with Bell’s palsy unconnected to the Pfizer vaccine. These type of misinforming mainstream media articles are commonly found to be using obvious fallacies to mislead their readership and with no individual taking responsibility for writing the misinforming piece, a trick repeated by many other media companies complicit with the official narrative. The Reuters article even goes on to admit that: “According to the FDA’s briefing document dated December 10, Bell’s palsy was reported in four vaccine participants and none in the placebo group, out of the 44,000 total participants of the late-stage vaccine trial.” However, the title of the Reuters article would mislead even some of the most keen eyed observers.
The mainstream media has been creating a flood of misleading stories, but it appears as though they have been given carte blanche to continue to do so, probably because they are sticking so tightly to the official narrative. It’s a narrative that is thick with irony, for it is the “trusted sources” who are being caught systematically misleading the general population again and again while also declaring a propaganda war against “fake news”.
The official guidance noted in Reg 174 doesn’t only highlight the serious lack of real data gained from Pfizer’s clinical trials for its Covid-19 vaccine so far, but it also exposes the wealthy medical professionals involved in these experimental vaccine development programs as complacent, reckless and very naive. It’s no secret that children are, more often than not, incapable of giving informed legal consent for such a risky and unethical enterprise. But the pro-vax extremists are using every tactic to coerce and manipulate children and their guardians into becoming human guinea pigs for Big Pharma. Pregnant women are also treated as acceptable collateral damage to advance the new science of gene, mRNA and DNA manipulation, a science and technology that pushes a sinister transhumanist agenda.
Don’t be fooled by the carefully worded vacuous celebrities, self-serving politicians, Big Pharma, and the mainstream medias authoritarian style misinformation campaigns. Keep your humanity intact and read their own words. The government guidance to healthcare professionals clearly states on multiple occasions that there are “no data available”.
Johnny Vedmore is a completely independent investigative journalist and musician from Cardiff, Wales. His work aims to expose the powerful people who are overlooked by other journalists and bring new information to his readers. If you require help, or have a tip for Johnny, then get in touch via johnnyvedmore.com or by reaching out to johnnyvedmore@gmail.com
Emergency Hospitals Dismantled Despite Claim Hospitalisations Worse Than ‘First Wave’
The hospitals have been almost completely empty for the duration of the health crisis
By Steve Watson | Summit News | December 29, 2020
A report has confirmed that emergency hospitals in the UK are being dismantled and removed, despite government claims that hospitalisations from coronavirus have hit a level HIGHER than they were during the first wave of the pandemic back in March and April.
The reports in the Daily Mail and the London Telegraph note that the facilities, known as ‘Nightingale hospitals’, set up at huge conference centres and other warehouse spaces are “being quietly taken apart” because there are not enough staff to run them.
Despite the seven facilities throughout the UK costing as much as £220million to set up and equip, the hospitals have been almost completely empty for the duration of the health crisis.
Indeed, just 57 Covid-19 patients were admitted to NHS Nightingale London between April and the start of May, according to Department of Health records. The facility was then put back into ‘standby’, and left empty.
The report states that the ExCeL Centre, which hosts the London facility, has confirmed that 90 per cent of the hospital has already been removed, including stripping 4000 beds and hundreds of additional of ventilators.
Videos of the facilities being dismantled first surfaced in the Summer:
The government has repeatedly pushed the narrative that the lockdowns have been necessary to ‘protect the NHS’, yet now it is taking apart the hospitals it says were set up to alleviate the strain.
It has been claimed that a third of major hospital trusts in England are now experiencing more Covid-19 patients than at the peak of the first wave. In the East and South West, more than half of all hospitals say they have more patients now than earlier in the year.
National Health Service data claims that over 20,000 beds are now occupied by COVID patients, up from 17,700 recorded last week, and surpassing the almost 19,000 recorded in mid April.
Throughout the crisis, we have been told that hospitals are on the brink of being overwhelmed, yet reports have continued to emerge suggesting that hospitals are up to four times emptier than usual.
Despite the claims that there are not enough NHS staff to man the facilities, there has been a resurgence of nurses posting dancing tik-tok videos:
Biden’s Pony Problem: Why The Hunter Biden Scandal Is No Dead Horse
By Jonathan Turley | December 23, 2020
President-elect Joe Biden has a pony problem. During the primary, Joe Biden bizarrely responded to a woman who asked why voters should believe that he could win a national election by saying “You’re a lying dog-faced pony soldier.” That encounter came to mind when Biden this week mocked Fox reporter Peter Doocy, who violated the virtual news blackout on the Hunter Biden story by asking about the scandal. Biden immediately walked off stage and then stopped and said “Yes, yes, yes. God love you, man — you’re a one-horse pony, I tell you.”
Like many kids this Christmas, many voters are still angling for a pony. Biden has spent months mocking the Hunter Biden story – and anyone asking about it. When CBS News reporter Bo Erickson asked Biden about his son’s scandal, Bo Erickson drew a similar rebuke from Biden. He simply asked ‘Mr. Biden, what is your response to the New York Post story about your son, sir?’ Biden’s response was again a personal attack: “I know you’d ask it. I have no response, it’s another smear campaign, right up your alley, those are the questions you always ask.” Biden also blew up at a question that referred by the scandal by a NBC reporter and at a Fox reporter who asked about his son.
It is just not working. The media openly worked to bury the Hunter Biden scandal before the election, but the ponies keep finding their way back. The problem is when you have one reporter like Doocy who refuses to be corralled and insists on an answer to a serious question.
The question yesterday was a good one. Doocy yelled out “Mr. President-elect, do you still think that the stories from the fall about your son Hunter were Russian disinformation and a smear campaign like you said?” Biden’s response of “yes, yes, yes” seemed to continue a discredited claim (indeed, “disinformation”) put out by figures like House Intelligence Committee Chairman Adam Schiff who assured the pubic that the allegations against “this whole smear on Joe Biden comes from the Kremlin.” Some 50 former intelligence officials, including Obama’s CIA directors John Brennan and Leon Panetta, also insisted the laptop story was likely the work of Russian intelligence. Cable hosts and journalists laughed at the laptop story as fake news to justify the blackout on coverage before the election.
Then the pony showed up again. After the election, it was confirmed (as some of us discussed in columns before the election) that Hunter Biden is under federal investigation. The laptop appears to be genuine. The emails appear to be genuine. And Doocy continued to ask the obvious questions.
Biden is still hoping that he can continue to mock and the media will continue to do the rest. One reporter yesterday did raise the scandal but only to ask if Biden discussed it with Attorney General candidates (the campaign already said that Biden was going to allow the Justice Department to reach its own conclusions). There are other obvious questions, including whether a key business associate of the Bidens, Anthony Bobulinski, is lying. Either Tony Bobulinski or Joe Biden is lying. Bobulinski is repeatedly praised by Hunter Biden in the emails and identified as the person in control of transactions for “the family.” He has directly contradicted Joe Biden’s denial of any knowledge or involvement in his son’s dubious dealings.
There is a reason why Biden may not want to answer that question. If he calls Bobulinski a liar, Biden would be hit with a defamation lawsuit within days. He would then be forced to go under oath. Such depositions present their own dangers. Just ask Bill Clinton. So it is not a pesky pony but a sworn deposition that Biden may be trying to avoid.
The same problem exists on other questions. For example, not only were Joe and Jill Biden included as “office mates” with controversial Chinese investor (and associate of Hunter) Gongwen Dong, but emails also refer to unsecured loans going to the Biden family and shares going to “the big guy.” The “big guy” appears to be Joe Biden. Moreover, Biden spent the election denying that his son did anything wrong and that he made no money from China. The question is when Biden learned of the federal investigation and whether he was aware of the dealings over multimillion dollar unsecured loans (as well as alleged gifts like a valuable diamond givento his son). Answering those questions falsely could trigger a congressional investigation and then more ponies would show up.
That is the problem with a bunker press strategy of denial and isolation. Like water, truth has a way of coming out. Clearly many in the media will continue to be in the bag for Biden. However, horses tend to gather where the water is found. First, there was one pony (Doocy). Then another showed up (Erickson). Before you know it, you have a herd and a threat of a stampede. Then it could be too late.
In the mocking comment to Doocy, Biden was clearly trying to say a “one-trick pony.” That trick however was once called “journalism” back in the day when reporters doggedly demanded answers, particularly on questions like influence peddling. So many of us still hoping for ponies – and even some answers – for Christmas.
New York Can’t Buy Its Way Out Of Blackouts
By David Wojick, Ph.D. ~ PA Pundits ~ December 26, 2020
New York City will soon be home to the world’s biggest utility-scale battery system, designed to back up its growing reliance on intermittent renewables. At 400 MWh this batch of batteries will be more than triple the 129 MWh world leader in Australia.
The City of New York’s director of sustainability (I am not making this title up), Mark Chambers, is ecstatic, bragging: “Expanding battery storage is a critical part of how we advance momentum to confront the climate emergency while meeting the energy needs of all New Yorkers. Today’s announcement demonstrates how we can deliver this need at significant scale.” (Emphasis added)
In reality the scale here is incredibly insignificant.
In the same nonsensical way, Tim Cawley, the president of Con Edison, New York’s power utility, gushes thus: “Utility scale battery storage will play a vital role in New York’s clean energy future, especially in New York City where it will help to maximize the benefit of the wind power being developed offshore.”
This puts the Con in Con Edison.
Here is the reality when it comes to the scale needed to reliably back up intermittent renewables. For simplicity let us suppose New York City is 100% wind powered. Including solar in the generating mix makes it more complicated but does not change the unhappy outcome very much.
NYC presently peaks at around 32,000 MW needed to keep the lights on. If Mr. Biden makes all the cars and trucks electric it might be closer to 50,000 MW but let’s stick to reality.
This peak occurs during summer heat waves which are caused by stagnant high pressure systems called Bermuda highs. These highs often last for a week and because they are stagnant there is no wind power generation. Wind turbines require something like sustained winds of 10 mph to move the blades and more like a whistling 30 mph to generate full power. During a Bermuda high folks are happy to get the occasional 5 mph breeze. These huge highs cover many states so it is not like we can get the juice from next door.
So for reliability we need, say, seven days of backup, which is 168 hours. Here’s the math:
32,000 MW x 168 hours = 5,376,000 MWh of stored juice needed to just make it. Mind you for normal reliability we usually add 20% or so. Did I mention electric cars?
It is easy to see that a trivial 400 MWh is not “significant scale.” It is infinitesimal scale. Nothing. Nada. Might as well not exist.
More specifically, 5,376,000 divided by 400 = 13,440 so only 13,439 more to go.
On the other hand, this measly 400 MWh battery array may well cost half a billion dollars, which is significant, especially to the New Yorkers who will pay for it. No cost figures are given because the system is privately owned, but EIA reports that the average utility scale battery system runs around $1.5 million a MWh of storage capacity. That works out to $600 million for this insignificant toy.
So what would it cost to reliably back up wind power, at this MWh cost and NYC’s scale? Just over $8,000,000,000,000 or EIGHT TRILLION DOLLARS. I have not seen this stupendous sum mentioned in the media. Perhaps Con Ed has not mentioned it.
Then too, New York State has the same problem. Only much bigger if New York City is included, which it often is.
But hey, maybe the cost will come down a few trillion. Not if we create a seller’s market by rushing into intermittent renewables, which is certainly where we are headed. After all, this is just New York City. Imagine what backing up America with batteries might cost. Don’t bother because it is impossible.
I should also add that we have no idea how to make 5 million MWh of batteries work together. The tiny 400 will be a challenge. It may not be possible.
Maybe fracked geothermal, the reliable renewable, is the answer. Or how about coal, oil, gas and nuclear power? Too bad they are all out of fashion.
All of this battery backup hype is a scam, and not just in New York either. The papers are full of this con, from coast to coast. The utilities know perfectly well that these loudly touted battery buys are a hoax, but they are getting rich building the wind and solar systems the politicians are calling for.
The voters are oblivious to these impossible numbers, since they are told that intermittent wind and solar are cheaper than reliable coal, gas and nuclear. Only when the sun shines bright and the wind blows hard, which is not all that often.
Reality is just sitting there, waiting. It can’t work so it won’t work. At this point it is just a question of how and when we find out the hard way.
Developers of Oxford-AstraZeneca Vaccine Tied to UK Eugenics Movement
By Jeremy Loffredo and Whitney Webb |
Unlimited Hangout| December 26, 2020
The developers of the Oxford-AstraZeneca vaccine have previously undisclosed ties to the re-named British Eugenics Society as well as other Eugenics-linked institutions like the Wellcome Trust.
On April 30th, AstraZeneca and Oxford University announced a “landmark agreement” for the development of a COVID-19 vaccine. The agreement involves AstraZeneca overseeing aspects of the development as well as manufacturing and distribution while the Oxford side, via the Jenner Institute and Oxford Vaccine Group, researched and developed the vaccine. Less than a month after this agreement was reached, the Oxford-AstraZeneca partnership was awarded a contract from the US government as part of Operation Warp Speed, the public-private COVID-19 vaccination effort dominated by the US military and US intelligence.
Though the partnership was announced in April, Oxford’s Jenner Institute had already begun developing the COVID-19 vaccine months before, in mid-January. According to a recent BBC report, it was in January that the Jenner Institute first became aware of how serious the pandemic would soon become, when Professor Andrew Pollard, who works for both the Jenner Institute and heads the Oxford Vaccine Group, “shared a taxi with a modeler who worked for the UK’s Scientific Advisory Group for Emergencies.” During the taxi ride, “the scientist told him data suggested there was going to be a pandemic not unlike the 1918 flu.” Due to this sole encounter, we are told, the Jenner Institute then began to pour millions into the early development of a vaccine for COVID-19 well before the scope of the crisis was clear.
For much of 2020, the Oxford-AstraZeneca vaccine was treated as an early front-runner, though its lead would later be marred by scandals related to its clinical trials, including the death of participants, sudden trial pauses, the use of a problematic “placebo” with its own host of side effects and the “unintentional” mis-dosing of some participants that skewed its self-reported efficacy rate.
The significant issues that emerged during trials have provoked little concern from the vaccine’s two lead developers, despite critical attention from even mainstream media of its complications. The lead developer of the Oxford-AstraZeneca vaccine, Adrian Hill, told NBC on December 9th that the experimental vaccine should be approved and distributed to the public before the conclusion of the safety trials, saying,”to wait for the end of the trial would be the middle of next year. That’s too late, this vaccine is effective, available at large scale and easily deployed.”
Sarah Gilbert, the other lead researcher on the vaccine, seemed to believe that pre-mature safety approval was likely, telling the BBC on December 13 that the chances of rolling out the vaccine by the end of the year are “pretty high.” Now, the UK is expected to approve the Oxford-AstraZeneca vaccine shortly after Christmas, with India also set to approve the vaccine next week.
While the controversies surrounding the vaccine’s trials did ultimately undermine its previous frontrunner status, the Oxford-AstraZeneca vaccine remains heavily promoted as the vaccine of choice for the developing world, as it is cheaper and has much less complicated storage requirement than its main competitors, Pfizer and Moderna.
Earlier this month, Dr. Richard Horton, the editor-in-chief of the Lancet medical journal, told CNBC that “The Oxford AstraZeneca vaccine is the vaccine right now that is going to be able to immunize the planet more effectively, more rapidly than any other vaccine we have” in large part because it is a “vaccine that can get to lower middle-income countries.” CNBC also quoted Andrew Baum, global head of health care for Citi Group, as saying that the Oxford-AstraZeneca vaccine “is really the only vaccine that is going to suppress or even eradicate SARS-CoV-2, the virus that causes COVID-19, in the many millions of individuals in the developing world.”
In addition to longstanding claims that the Oxford-AstraZeneca vaccine will be the vaccine of choice for the developing world, this vaccine candidate has also been treated by several outlets in the mainstream and even independent media as “good for people, bad for profits” due to the partnership’s “explicit intention of supplying [the vaccine] around the world on a not-for-profit basis, meaning that the poorest nations on the planet will not have to worry about being shut out of a cure due to lack of funds.”
However, investigation into the vaccine’s developers and the realities of their “no-profit pledge” reveals a very different story than that which has been spun for most of the year by corporate press releases, experts and academics tied to the vaccine and the mainstream press.
For instance, mainstream media has had little, if anything, to say about the role of the vaccine developers’ private company – Vaccitech – in the Oxford-AstraZeneca partnership, a company whose main investors include former top Deutsche Bank executives, Silicon Valley behemoth Google and the UK government. All of them stand to profit from the vaccine alongside the vaccine’s two developers, Adrian Hill and Sarah Gilbert, who retain an estimated 10% stake in the company. Another overlooked point is the plan to dramatically alter the current sales model for the vaccine following the initial wave of its administration, which would see profits soar, especially if the now obvious push to make COVID-19 vaccination an annual affair for the foreseeable future is made reality.
Yet, arguably most troubling of all is the direct link of the vaccine’s lead developers to the Wellcome Trust and, in the case of Adrian Hill, the Galton Institute, two groups with longstanding ties to the UK Eugenics movement. The latter organization, named for the “father of eugenics” Francis Galton, is the re-named UK Eugenics Society, a group notorious for its promotion of racist pseudoscience and efforts to “improve racial stock” by reducing the population of those deemed inferior for over a century.
The ties of Adrian Hill to the Galton Institute should raise obvious concerns given the push to make the Oxford-AstraZeneca vaccine he developed with Gilbert the vaccine of choice for the developing world, particularly countries in Latin America, South and Southeast Asia and Africa, the very areas where the Galton Institute’s past members have called for reducing population growth.
In the final installment of this series on Operation Warp Speed, the US government’s vaccination effort, and race, the Oxford-AstraZeneca vaccine’s ties to Eugenics-linked institutions, the secretive role of Vaccitech, and the myth of the vaccine’s sale being “non-profit” and altruistically motivated are explored in detail.
GlaxoSmithKline and the Jenner Institute
The Edward Jenner Institute for Vaccine Research was initially established in 1995 in Compton in Berkshire as a public-private partnership between the UK government, via the Medical Research Council and the Department of Health, and the pharmaceutical giant GlaxoSmithKline. Following a “review by the [institute’s] sponsors,” it was relaunched in 2005 in Oxford under the leadership of Adrian Hill, who—prior to that appointment—held a senior position at the Wellcome Trust’s Centre for Human Genetics. Hill, the lead developer of the Oxford-AstraZeneca COVID-19 vaccine, still leads a research group at Wellcome aimed at “understand[ing] the genetic basis of susceptibility to different infectious diseases, especially. . . severe respiratory infections,” which conducts most of its studies in Africa. The UK’s Medical Research Council has also become a collaborator with the Wellcome Trust, specifically on vaccine-related initiatives. The Wellcome Trust, discussed at greater length later in this article, was originally created with funding from Henry Wellcome, who founded the company that later became GlaxoSmithKline.
Hill’s partner at the Jenner Institute and the other co-developer of the Oxford COVID-19 vaccine is Sarah Gilbert. Gilbert also hails from the Wellcome Trust, where she was a “program director,” and is a student of Hill’s. Together, Gilbert and Hill have worked to position the institute to be the center of all future vaccination efforts undertaken in response to global pandemics.
Professor Sarah Gilbert at Oxford, Photo by John Cairns
The Jenner Institute’s relocation to Oxford was largely facilitated by the Medical Research Council, which donated £1.25 million between 2005 and 2006, after the decision was made to replace the institute’s original sponsors (GlaxoSmithKline, the Medical Research Council, the Department of Health) with the University of Oxford and the Institute for Animal Health, now called the Pirbright Institute. The involvement of Pirbright meant that the relaunched Jenner Institute became unique in developing vaccines for both humans and livestock.
The relaunched Jenner Institute has come to dominate publicly funded vaccine development in the UK as well as the testing of vaccines produced by the world’s largest pharmaceutical companies via clinical trials and has overseen prominent safety trials for vaccines of high media interest in recent years. Some of the Jenner Institute–conducted trials later drew controversy, such as those using South African infants in 2009 in which seven infants died.
An investigation conducted by the British Medical Journal found that the Hill-led Jenner Institute had, in the South African instance, knowingly misled parents about the negative results of and questionable methods used in animal studies as well the vaccine being known to be ineffective. The vaccine in question, an experimental tuberculosis vaccine developed jointly by Emergent Biosolutions and the Jenner Institute, was scrapped after the controversial study in infants confirmed what was already known, that the vaccine was ineffective. The trial, largely funded by Oxford and the Wellcome Trust, was subsequently praised as “historic” by the BBC. Hill, at the time the study was conducted, had a personal financial stake in the vaccine.
Similar instances of dodgy practices in efficacy trials and the effects of increased dosages have led vaccine experts to criticize the COVID-19 vaccine developed by Hill and Gilbert. Hill and Gilbert hold a considerable financial stake in the Oxford-AstraZeneca COVID-19 vaccine. While the vaccine reportedly has an efficacy of over 90 percent, those figures—often cited in mainstream reports—are self-reported by the vaccine’s developers and manufacturers (i.e., the Oxford team and AstraZeneca), which is significant given that Hill and other Jenner Institute scientists have previously been caught manipulating trial results to benefit a vaccine product in which they were personally invested.
The prominence of the Jenner Institute in vaccine development and testing has largely come through Hill’s additional leadership role at the UK’s Vaccines Network, which chooses what vaccines to develop, how to develop them, and which firms should receive “targeted investments” from the UK government. The Vaccines Network also plays a key role in identifying “what vaccine technologies could play an important role in future outbreaks.” Two of the main backers of the UK’s Vaccines Network are the Wellcome Trust and GlaxoSmithKline.
Unsurprisingly, the Vaccines Network has steered many millions of pounds toward the Hill-run Jenner Institute, with completed projects including a “plug and display” virus-like particle platform for rapid-response vaccination. Also funded by the Vaccines Network were the Jenner Institute’s initial studies of novel chimpanzee adenovirus vaccines for coronavirus (in this case, MERS), the same viral vector used for the Oxford-AstraZeneca vaccine. In addition to the Vaccines Network, the Jenner Institute also coordinates the efforts of the EU’s Vaccines Network equivalent, MultiMalVax.
Professor Adrian Hill at the Jenner Institute, Photo by John Cairns
The Jenner Institute also has a close relationship with GlaxoSmithKline and the Italian biotech Okairos, which was acquired by GlaxoSmithKline in 2014. Soon after it was acquired, Okairos, and its new owner GlaxoSmithKline, became key players in the 2014 experimental Ebola vaccine push, an effort that mirrors the current COVID-19 vaccine development rush in many key ways. The rushed safety trials for that vaccine were overseen by Adrian Hill and the Jenner Institute and funded by the UK government and the Wellcome Trust. GlaxoSmithKline and Okairos are the only firms represented on the Jenner Institute’s Scientific Advisory Board.
The Jenner Institute, along with GlaxoSmithKline-Okairos and a small French biotech called Imaxio, have been developing an experimental malaria vaccine since 2015, with human trials of that vaccine announced on December 12, 2020. Those trials will be conducted on 4,800 children in Africa over the course of 2021, in many of the same countries where Hill’s research group at the Wellcome Center for Human Genetics has been studying genetic susceptibility to several diseases. “A lot more people will die in Africa this year from malaria than will die from Covid,” Hill recently said in regard to the soon-to-begin trials.
Currently, the Jenner Institute is funded by the Jenner Vaccine Foundation, but the foundation’s documents note on several occasions a considerable influx of money from Wellcome Trust Strategic Awards. A “special review panel” from the Wellcome Trust actually lobbied the Jenner Institute to apply for further “strategic core funding” from the trust after visiting the institute and appraising its work. The Jenner Institute frames its funding from Wellcome as the key guidance behind its development decisions, which are made “based on the successful model of Wellcome Trust Strategic Award support.”
The Jenner Institute’s foundation, however, is not the only source of income for its lead researchers. Hill and Gilbert have been working to commercialize many of the institute’s vaccines through their own private company, Vaccitech. Though media reports often describe the vaccine as being a joint effort between AstraZeneca and the University of Oxford, Vaccitech is a key stakeholder in that partnership, given that the vaccine candidate relies on technology developed by Hill and Gilbert and owned by Vaccitech. A deeper look into Vaccitech offers a clue as to why the company’s name has been absent from nearly all media reports on the Oxford-AstraZeneca vaccine, as it demolishes the much-touted claim that the vaccine is “nonprofit” and offered at low cost for charitable reasons.
Vaccitech: doing well by going “good”?
The official reason Sarah Gilbert and Adrian Hill created Vaccitech in 2016 per The Times is because “Oxford’s researchers [are] encouraged to form companies to commercialize their work.” Vaccitech, like other “commercialized” Oxford research enterprises, was spun out of the Jenner Institute via the university’s commercialization arm, Oxford Science Innovations, which is currently Vaccitech’s largest stakeholder at 46 percent. Hill and Gilbert are reported to maintain a 10 percent stake in the company.
The largest investor in Oxford Science Innovations, and by extension one of the largest shareholders in Vaccitech, is Braavos Capital, the venture-capital firm started in 2019 by Andrew Crawford-Brunt, Deutsche Bank’s long-time global head of equity trading at its London branch. Through its stake in Oxford Science Innovations, Braavos owns about 9 percent of Vaccitech.
Prior to COVID-19, Vaccitech’s main focus, especially last year, was the development of a universal vaccine for the flu. Vaccitech’s efforts in this regard were praised by Google, which is also invested in Vaccitech. At the same time, the Bill & Melinda Gates Foundation was funding research to develop a universal flu vaccine, reportedly because the field of influenza vaccinology was not yet able “to design a flu vaccine that would protect broadly against the strains of flu that infect people every winter and those in nature that could emerge to trigger a disruptive and deadly pandemic,” according to a STAT News report from last year. The Gates Foundation effort originally partnered with Google’s cofounder Larry Page and his wife Lucy.
To fully finance Hill and Gilbert’s Vaccitech, and specifically its quest to develop a universal flu vaccine, Oxford Science Innovations sought £600 million from “outside investors,” chief among them the Wellcome Trust and the venture-capital arm of Google, Google Ventures. This means that Google is poised to make a profit from the Oxford-AstraZeneca vaccine at a time when its video platform YouTube has moved to ban COVID-19 vaccine–related content that shines a negative light on COVID-19 vaccines, including the Oxford-AstraZeneca candidate. Other investors in Vaccitech include Sequoia Capital’s Chinese branch and the Chinese pharmaceutical company Fosun Pharma. In addition, the UK government has put an estimated £5 million into the company and is also expected to make a return on the Oxford-AstraZeneca vaccine.
Vaccitech’s homepage showing company co-founders Adrian Hill and Sarah Gilbert. From vaccitech.co.uk
Information on the profit motive behind the Oxford-AstraZeneca vaccine has been muddied due to the extensive media promotion of the claim that Hill and Gilbert will not be collecting royalties on the vaccine and that AstraZeneca is not making a profit off the vaccine. However, this is only true until the pandemic is “officially” declared over, and the virus is labeled a persistent or seasonal condition that will require the mass administration of COVID-19 vaccines at regular intervals and possibly annually. Sky News reported that the determination of when the pandemic is over “will be based on the views of a range of [unspecified] independent bodies.” At that point, both Vaccitech and Oxford will obtain royalties from AstraZeneca’s sales of the vaccine.
Those tied to the vaccine have been at the center of promoting the idea that the COVID-19 vaccine will soon become an annual affair. For instance, in early May, John Bell—an Oxford medical professor and an “architect” of the Oxford-AstraZeneca partnership—told NBC News, “I suspect we may need to have relatively regular vaccinations against coronaviruses going into the future,” adding that the vaccine would likely be needed every year like the flu vaccine. NBC News failed to note that the Oxford-AstraZeneca vaccine in which Bell is involved stands to significantly benefit financially if that does come to pass.
More recently, Bell told The Week that, “should there prove to be a market for regular vaccinations against coronavirus in the future, ‘there is some money to be made.’” Such sentiments have been echoed by Pascal Soriot, the CEO of AstraZeneca, who told Bloomberg last month that the company stood to make a “reasonable profit” once the pandemic was declared over and COVID-19 deemed a seasonal illness requiring regular vaccinations. On this matter, Vaccitech’s CEO, Bill Enright, stated that Vaccitech investors would receive a “big chunk of the royalties from a successful vaccine as well as ‘milestone’ payments” if and when the pandemic is declared over and COVID-19 vaccines become a seasonal event.
Vaccitech, in particular, appears quite certain that this possibility is slated to become reality. For all subsequent iterations of the Oxford-AstraZeneca vaccine, Vaccitech will reacquire a much larger percentage of rights to the vaccine, rights it is currently splitting with Oxford for the first iteration. Sky News has noted that the technology that Vaccitech owns “could drive the second generation of COVID-19 vaccines” and that it “has [already] received £2.3 million of public funding to develop it.”
US government officials such as Anthony Fauci have also signaled that the COVID-19 vaccine will require annual shots. Notably, the government, through Health and Human Service’s BARDA, has poured over $1 billion into the Oxford-AstraZeneca vaccine development. In addition to government officials, several recently published mainstream media reports have claimed that the “expert” consensus “seem[s] to be leaning toward an annual shot like the flu vaccine” with regards to the COVID-19 vaccine. For instance, Dr. Charles Chiu, a professor of infectious diseases at the University of California–San Francisco, recently told Salon, “This may end up being a vaccine that’s not a one-time thing or even a two-time thing. . . it may end up being what we call either a seasonal vaccine, or vaccine that needs to be administered every couple of years.”
Such hints about an annual COVID-19 vaccine from 2021 onward have recently become commonplace from the leading COVID-19 vaccine manufacturers themselves. For instance, on December 13th, Pfizer CEO Albert Bourla was quoted by the Telegraph as saying, “How long this [vaccine] protection lasts is something we don’t know … I think it is a likely scenario that you will need periodical vaccinations.” Pfizer also recently issued a statement that noted that “we don’t know how the virus will change, and we also don’t know how durable the protective effect of any vaccination will be,” adding that its vaccine would be suitable “for repeated administration as booster shots” in the event that the vaccine only induces an immune response for a few months.
Then, this past Tuesday, Moderna released information that suggested immunity from its COVID-19 vaccine would only last several months, with Forbes writing that “the duration of neutralizing antibodies from the Moderna vaccine will be relatively short, potentially less than a year,” an outcome that would favor the push for an annual COVID-19 shot. The developer of the Pfizer COVID-19 vaccine, Ugur Sahin of BioNTech, also stated on Tuesday that “The virus will stay with us for the next 10 years… We need to get used to the fact there’ll be more outbreaks.” He later added that “if the virus becomes more efficient… we might need a higher uptake of the vaccine for life to return to normal,” implying that these regular outbreaks he foresees occurring over the next ten years would be correlated with increased vaccine administration.
Quotes from the developers of the Oxford-AstraZeneca vaccine themselves also point to a pandemic-dominated future and a desire for the crisis to be prolonged so that the vaccine can be widely distributed. Gilbert told the UK Independent in August that she believes COVID-19 is just the beginning and that COVID-like pandemics will become more frequent in the near future. The Jenner Institute vaccine team seems so determined to create the COVID vaccine that, in June, Hill was quoted by the Washington Post in June as stating that he wanted the pandemic to stick around, saying, “We’re in the bizarre position of wanting COVID to stay, at least for a little while. But cases are declining.” He also stated that his team was in “a race against the virus disappearing.”
With the vaccine developers, “medical experts,” government officials, and the CEOs of major vaccine manufacturers all agreeing that a seasonal COVID-19 vaccine is an increasingly likely outcome, it is worth considering a possible ulterior motive regarding the initial “nonprofit” model being used by the Jenner Institute/Vaccitech and AstraZeneca for their joint COVID-19 vaccine.
Given that vaccine guidance in several countries states that each dose of the multidose COVID-19 vaccine must be produced by the same manufacturer as previous doses, the implication is that in the event of a need for periodic COVID-19 vaccine variants, those who initially received the Oxford-AstraZeneca vaccine would likely be required to receive that same “brand” of vaccine seasonally. In other words, those who initially received the Oxford-AstraZeneca vaccine would likely be required, not just to receive a second dose of the same “brand,” but continue receiving that same “brand” of vaccine every year. Notably, no interaction studies have yet been conducted on the interactions between the COVID-19 vaccines and other medications as well as other vaccines.
If this turns out to be the case, it would certainly behoove the Oxford-Vaccitech-AstraZeneca team to want their vaccine to be the most widely used one in the first year in order to guarantee the largest market for subsequent annual COVID-19 vaccines. This could be a possible motive behind the efforts of the Oxford-AstraZeneca partnership “to supply the entire world with the Oxford jab” and to supply the vaccine “to the most vulnerable groups to COVID-19.” This vaccine has already been purchased, even before regulatory approval, by governments around the world, including in Europe, North America, Australia and most Latin American countries.
The Wellcome Trust
Adrian Hill currently holds a senior position at the Wellcome Trust’s Centre for Human Genomics. The Wellcome Trust is a scientific charity based in London, established in 1936 with funds from pharmaceutical magnate Henry Wellcome. As previously mentioned, Wellcome founded the pharmaceutical company that eventually became the industry giant GlaxoSmithKline. Today, the Wellcome Trust has a $25.9 billion endowment and engages in philanthropic endeavors, including funding clinical trials and research.
Hill has been closely tied to Wellcome for decades. In 1994, he participated in the founding of the Wellcome Centre for Human Genetics and was awarded a Wellcome Trust Principal Research Fellowship the following year. He became a Wellcome professor of human genetics in 1996.
The Wellcome Centre for Human Genetics website boasts of the large-scale genetic mapping they’ve conducted in Africa. The center also publishes papers that explore genetic dispositions in relation to male fertility and “reproductive success.” The crossroads between race and genes is important in the center’s work, as an entire working group at the center, the Myers Group, is dedicated to mapping the “genetic impacts of migration events.” The center also funded a paper that argued that so long as eugenics is not coercive it’s an acceptable policy initiative. The paper asks, “Is the fact that an action or policy is a case of eugenics necessarily a reason not to do it?” According to Hill’s page on the Wellcome Trust site, race and genetics have long played a central role in his scientific approach, and his group currently focuses on the role genetics plays in African populations with regard to susceptibility to specific infectious diseases.
The Wellcome Genome Campus, which houses the Wellcome Centre for Human Genetics, is located on the grounds of Hixton Hall, in Cambridgeshire, England.
Of even greater concern, last year Science Mag reported that Wellcome was accused by both a whistleblower and the University of Cape Town South Africa of illegally exploiting hundreds of Africans by “commercializing a gene chip without proper legal agreements and without the consent of the hundreds of African people whose donated DNA was used to develop the chip.” Jantina de Vries, a bioethicist at the University of Cape Town South Africa told the journal that it was “clearly unethical.” Since the controversy, other African institutions and peoples such as the indigenous Nama peoples of Namibia have demanded that Wellcome return the DNA it collected.
The Wellcome Centre regularly co-funds the research and development of vaccines and birth control methods with the Gates Foundation, a foundation that actively and admittedly engages in population and reproductive control in Africa and South Asia by, among other things, prioritizing the wide-spread distribution of injectable long-acting, reversible contraceptives (LARCs). The Wellcome Trust has also directly funded studies that sought to develop methods to “improve uptake” of LARCs in places such as rural Rwanda.
As researcher Jacob Levich wrote in the Palgrave Encyclopedia of Imperialism and Anti-Imperialism, LARCs afford women in the Global South “the least choice possible short of actual sterilization.” Some LARCs can render women infertile for as long as five years, and, as Levich argues, they “leave far more control in the hands of providers, and less in the hands of women, than condoms, oral contraceptives, or traditional methods.”
One example is Norplant, a contraceptive implant manufactured by Schering (now Bayer) that can prevent pregnancy for up to five years. It was taken off the US market in 2002 after more than fifty thousand women filed lawsuits against the company and the doctors who prescribed it. Seventy of those class action suits were related to side effects such as depression, extreme nausea, scalp-hair loss, ovarian cysts, migraines, and excessive bleeding.
Slightly modified and rebranded as Jadelle, the dangerous drug was promoted in Africa by the Gates Foundation in conjunction with USAID and EngenderHealth. Formerly named the Sterilization League for Human Betterment, EngenderHealth’s original mission, inspired by racial eugenics, was to “improve the biological stock of the human race.” Jadelle is not approved by the FDA for use in the United States.
Another scandal-ridden LARC is Pfizer’s Depo-Provera, an injectable contraceptive used in several African and Asian countries. The Gates Foundation and USAID have collaborated to fund this drug’s distribution and introduce it into the health-care systems of countries including Uganda, Burkina Faso, Nigeria, Niger, Senegal, Bangladesh, and India.
Andrew Pollard, director of the Oxford Vaccine Group, where Hill’s Jenner Institute resides, is enmeshed with the Gates Foundation. His employer, the University of Oxford, has received $11 million for vaccine development research from the foundation over the past three years and $208 million in grants over the past decade. In 2016, the Gates Foundation gave $36 million to a team of researchers that was headed by Pollard for vaccine development. In addition, Pollard’s private laboratory is funded by the Gates Foundation. Given this, it should come as no surprise that the Global Alliance for Vaccine Initiative (GAVI), a public-private partnership founded and currently funded by the Bill & Melinda Gates Foundation, plans to distribute the Oxford-AstraZeneca COVID-19 vaccine to low-income, predominantly African and Asian, countries once it’s approved.
The Galton Institute: Eugenics for the Twenty-First Century
Both the Wellcome Trust and Adrian Hill share a close relationship with the most infamous eugenics society in Europe, the British Eugenics Society. The Eugenics Society was renamed the Galton Institute in 1989, a name that pays homage to Sir Francis Galton, the so-called father of eugenics, a field that he often described as the “science of improving racial stock.”
In the case of the Wellcome Trust, the Trust’s library is the guardian of the Eugenics Society historical archives. When the Wellcome Trust first set up its Contemporary Medical Archive Center, the first organizational archive it sought to acquire was tellingly that of the Eugenics Society-Galton Institute. Wellcome’s website describes the Eugenics Society’s original purpose as “to increase public understanding of heredity and to influence parenthood in Britain, with the aim of biological improvement of the nation and mitigation of the burdens deemed to be imposed on society by the genetically ‘unfit’.” It also states the interests of the society’s members “ranged from the biology of heredity, a subject that developed rapidly during the first half of the 20th century, to the provision of birth control methods, artificial insemination, statistics, sex education and family allowances.” Lesley Hall, Wellcome’s senior archivist, has referred to Francis Galton, a racist eugenicist, as an “eminent late nineteenth century polymath” in her discussion of the Eugenics Society archive held at Wellcome.
A poster published by the Eugenics Society-Galton Institute in the 1930S, from the Wellcome Library
Several top governance positions at the former British Eugenics Society, now the Galton Institute, include individuals who originally worked at The Wellcome Trust, including the Galton Institute’s president Turi King. Dr. Elena Bochukova, a current Galton Council Member and Galton lecturer, previously worked under the direction of Adrian Hill at the Wellcome Trust Center for Human Genetics. The Galton Institute’s Senior Genetics Researcher, Dr. Jess Buxton, was previously a ‘genetics researcher’ at the Wellcome Trust and then went on to carry out independent research financed by Wellcome. Her research, which is particularly race oriented, includes creating the first genetic sequence map of a native Nigerian. Moreover, Adrian Hill himself spoke at the Eugenics Society-Galton Institute at the celebration of their 100th anniversary in 2008.
The Galton Institute publishes what they now call the Galton Review, previously titled the Eugenics Review, where various members of the self-proclaimed “learned society” publish papers focused on population issues, genetics, evolutionary biology, and fertility.
A look at early issues of the Eugenics Review shines a light on Galton’s original ambitions. In the 1955 issue titled “The Immigration of Colored People,” an author asks, “What will become of our national character, good workmanship etc. in the course of a few decades if this immigration of negroes and negroids continues unchecked?” The article ends with an appeal to readers to write their parliamentary representatives and urge them that in view of “racial betterment or deterioration” something must be done urgently to “check the present influx of africans and other negroids.”
Today, it appears that the Galton Institute continues to see the immigration of racial minorities into European cities as an unchecked threat. Mike Coleman, an Oxford professor of demographics and a fellow at the institute runs an anti-immigration organization and advocacy group called MigrationWatch—whose mission is to preserve the European culture of the UK by lobbying the government to stem legal immigration and publishing data that supposedly demonstrates the biological and cultural threat of increasing immigration.
A 1961 issue of the Eugenics Review titled “The Impending Crisis” claims the function of the institute’s upcoming conference is “to honor Margaret Sanger” and describes the population crisis as “quantity threatening quality.”
Sanger, known as the “pioneer of the American birth control movement,” was a staunch advocate for promoting “racial betterment” and the key architect of the Negro Project, which she claimed “was established for the benefit of the colored people.” But as medical ethics fellow at Harvard Medical School, Harriet Washington, argues in her book Medical Apartheid, “The Negro Project sought to find the best way to reduce the black population by promoting eugenic principals.” Sanger was an American member of the British Eugenics Society.
Another early member of the Galton Institute was John Harvey Kellogg, prominent business man and eugenicist. Kellogg founded the Race Betterment Foundation and argued that immigrants and nonwhites would damage the American gene pool. Yet another example is Charles Davenport, a scientist known for his collaborative research efforts with eugenicists in Nazi Germany and his contributions to Nazi Germany’s brutal racial policies, who was vice president of the Galton Institute in 1931.
Another more recent member of the Galton Institute was David Weatherall, for whom the Weatherall Institute of Molecular Medicine at Oxford is named. Weatherall was a member of the Galton Institute when it was still named the Eugenics Society and he remained a member until his death in 2018. Weatherall, who was knighted by the British monarch in 1987 for his contributions to science, addressed the Galton Institute on numerous occasions and gave a senior lecture on genetics at the institute in 2014, of which no transcript or video is available. As an Oxford professor, Weatherall was Adrian Hill’s doctoral adviser and eventually his boss when Hill began working at the Weatherall Institute conducting immunogenic research in Africa. A key fixture of the Weatherall Institute of Molecular Medicine since its founding is Walter Bodmer, a former president of the Galton Institute.
While the Galton Institute has attempted to distance itself from its past of promoting racial eugenics with surface-level public relations efforts, it has not stopped family members of the infamous racist from achieving leadership positions at the institute. Emeritus professor of molecular genetics at the Galton Institute and one of its officers is none other than David. J Galton, whose work includes Eugenics: The Future of Human Life in the 21st Century. David Galton has written that the Human Genome Mapping Project, originally dreamt up by Galton’s former president Walter Bodmer, had “enormously increased . . . the scope for eugenics . . . because of the development of a very powerful technology for the manipulation of DNA.”
This new “wider definition of eugenics,” Galton has said, “would cover methods of regulating population numbers as well as improving genome quality by selective artificial insemination by donor, gene therapy or gene manipulation of germ-line cells.” In expanding on this new definition, Galton is neutral as to “whether some methods should be made compulsory by the state, or left entirely to the personal choice of the individual.”
Who gets the safest vaccines?
Considering the degree to which the players and institutions behind the Oxford-AstraZeneca vaccine (including the lead developer) are tied and connected to institutions that have been instrumental in the rise and perpetuation of racial eugenics, it’s concerning that this particular vaccine is being portrayed by scientists and media alike as the COVID-19 vaccine for the poor and the Global South.
The Oxford-AstraZeneca vaccine sells at a fraction of the cost of its COVID-19 vaccine competitors—running between 3 and 5 dollars per dose. Moderna and Pfizer cost 25 to 37 dollars and 20 dollars per dose, respectively. As CNN recently reported, the Oxford-AstraZeneca vaccine will “be far easier to transport and distribute in developing countries than its rivals,” several of which require complicated and costly cold supply chains. When the Thomson Reuters Foundation asked several experts which COVID-19 vaccine could “reach the poorest soonest,” all declared a preference for the Oxford-AstraZeneca candidate.
There is also the added fact that a host of safety issues have come to surround the vaccine. Recently, on November 21, a forty-year-old participant in AstraZeneca’s clinical trial who lives in India sent a legal notice to the Serum Institute of India alleging that the vaccine caused him to develop acute neuroencephalopathy, or brain damage. In the notice, the participant said he “must be compensated, in the least, for all the sufferings that he and his family have undergone and are likely to undergo in the future.”
In response, the Serum Institute claimed the participant’s medical complications are unrelated to the vaccine trial and said it would take “legal action” against the brain-damaged participant for maligning the company’s reputation, seeking damages in excess of $13 million. “This is the first time I have ever heard of a sponsor threatening a trial participant,” Amar Jesani, editor of the Indian Journal of Medical Ethics, said of the incident. The Serum Institute has received at least $18.6 million from the Bill & Melinda Gates Foundation and has a deal with AstraZeneca to manufacture a billion doses of the vaccine.
Other manufacturers chosen by Oxford-AstraZeneca to produce their vaccine are also no strangers to controversy. For instance, their manufacturing partner in China, Shenzhen Kangtai Biological Products, has been at the center of controversy for years, especially after 17 infants died from its Hepatitis B vaccine in 2013. The New York Times cited Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations, as saying: “Imagine if a similar scandal is reported again in China… It’s not just going to undermine the confidence of the company manufacturing the vaccine, it’s also going to hurt the reputation of AstraZeneca itself and their vaccine, too.”
In another example, the manufacturing partner chosen to produce the vaccine in the US is the scandal-ridden company with ties to the 2001 anthrax attacks, Emergent Biosolutions. Emergent Biosolutions, previously known as BioPort, has a long track record of knowingly selling and marketing products that were never tested for safety and efficacy, including its anthrax vaccine BioThrax and its biodefense product Trobigard. The current head of quality control for Emergent Biosolutions’ lead manufacturing facility in the US has no expertise in pharmaceutical manufacturing and is instead a former high-ranking military intelligence official who operated in Iraq, Afghanistan and beyond.
The issues raised by their decision to partner with manufacturers with dark histories of product safety issues are compounded by the adverse reactions reported in the Oxford-AstraZeneca trials as well as the ways in which those trials have been conducted. In September, AstraZeneca was forced to pause its experimental COVID-19 vaccine trial after a woman in the UK developed a “suspected serious reaction” that the New York Times reported was consistent with transverse myelitis. TM is a neurological disorder characterized by inflammation of the spinal cord, a major element of the central nervous system. It often results in weakness of the limbs, problems emptying the bladder, and paralysis. Patients can become severely disabled, and there is currently no effective cure.
Concern over an association between TM and vaccines is well established. A review of published case studies in 2009 documented thirty-seven cases of TM associated with various vaccines, including hepatitis B, measles-mumps-rubella, diphtheria, pertussis, tetanus, among others in infants, children, and adults. The researchers in Israel noted, “The associations of different vaccines with a single autoimmune phenomenon allude to the idea that a common denominator of these vaccines, such as an adjuvant, might trigger this syndrome.” Even the New York Times article on the AstraZeneca trial pause notes past “speculation” that vaccines might be able to trigger TM.
In July, an Oxford-AstraZeneca trial participant developed symptoms of TM, and the vaccine trial was paused at that time. An “independent panel” ultimately concluded the illness was unrelated to the vaccine, and the trial continued. Yet, as Nikolai Petrovsky from Flinders University told the Australian Broadcasting Corporation, these panels are typically made up of “biostatisticians and also medical representatives from the sponsor drug company running the trial.” Then, in October, a trial participant in Brazil died, though in that case, AstraZeneca suggested that the person was part of the control group and thus hadn’t received the COVID-19 vaccine.
According to Forbes, the AstraZeneca vaccine was ineffective at stopping the spread of coronavirus in their animal trials. All six monkeys injected with AstraZeneca’s COVID-19 vaccine became infected with the disease after being inoculated. All the monkeys were put to death, which means that it will remain unknown whether those monkeys would have suffered other adverse effects.
Another concern is that trial administrators gave the trial control group (for both human and animal trials) Pfizer’s Nimenrix, a meningitis vaccine, as opposed to a saline solution, which is regarded as the gold standard for controls because researchers can be sure the saline solution won’t cause any adverse reactions. Using Pfizer’s meningitis vaccine as the control placebo allows AstraZeneca to downplay any adverse reactions in its COVID-19 vaccine group by showing that the control group suffered adverse reactions as well. “The meningitis vaccine in the AstraZeneca trial is what I would call a ‘fauxcebo,’ a fake control whose real purpose is to disguise or hide injury in the vaccine group,” said Mary Holland, general counsel at Children’s Health Defense.
Eugenics under another name
Despite these safety concerns and clinical trial scandals, close to 160 countries have purchased the Oxford-AstraZeneca vaccine, and now reports are suggesting that India, the country with the second largest population on Earth, is likely to approve this vaccine by next week.
As documented here, while the vaccine may be heralded as “vital for lower-income countries,” the Oxford-AstraZeneca project is no mere philanthropic pursuit. Not only is there a significant profit motive behind the vaccine, but its lead researcher’s connection to the British Eugenics Society adds another level of warranted scrutiny.
For those encountering stories of eugenicists, it’s common to dismiss such activity as that of “conspiracy theories.” However, it’s undeniable that several prominent individuals and institutions that remain active today have clear ties to eugenicist thinking, which was not so taboo just a few decades ago. Unfortunately, this holds true for the individuals and institutions associated with the Oxford-AstraZeneca COVID vaccine, who, as demonstrated in this article, immerse themselves in studies of race science and population control – primarily in Africa while working closely with institutions that have direct and longstanding links to the worst of the Eugenics movement.
As this series has shown, there are many concerns regarding the points where race and the COVID-19 vaccination campaign in the US and abroad intersect, both publicly and privately. Part I of this series raised questions about the policy-shaping role of the Johns Hopkins Center for Health Security, which suggested that the US government make COVID-19 vaccines available to ethnic minorities and the mentally challenged first. Part II explained how in order to allocate COVID-19 vaccines in the US, health agencies are using a program created by Palantir, a company with a record of helping the US agencies target ethnic minorities through immigration policy and racist policing.
Furthermore, there are plans in place to exercise what could reasonably be described as economic coercion to pressure people to “voluntarily” get vaccinated. Such coercion will be obviously be more effective on poor and working communities, meaning communities of color will be disproportionately affected as well.
Considering these facts, and the case for scrutinizing the safety of Oxford-AstraZeneca’s “affordable” vaccine option made above, any harm caused by vaccine allocation policy in the US and beyond is likely to disproportionately affect poor communities, especially communities of color.
As such, the public should take all vaccine rollout policy with a grain of salt, even when they come cloaked in language of inclusion, racial justice, and public health preservation. As the co-founder of the American Eugenics Society (later renamed “Society for the Study of Social Biology”) Frederick Osborn put it in 1968, “Eugenic goals are most likely to be attained under a name other than eugenics.”
Featured Video
Roosevelt’s Partnership with Stalin
or go to
Aletho News Archives – Video-Images
From the Archives
“Democratic Institutions?” – 10 Lessons from history that will destroy your trust in the CIA
By Kit | OffGuardian | July 20, 2018
… At every corner, we are urged to simply believe what we are told. Whether it is about believing Porton Down and MI6 about “novichok”, or believing the White Helmets about Sarin, or believing the FBI about “collusion”, we are presented with no facts, just assertions from authority. Those who question those assertions are deemed “bots” at best or “traitors” at worst.
Well here, fellow traitors, are the Top Ten reasons to question anything and everything the CIA – or any intelligence agency – has ever told you. … Read full article
Blog Roll
Aletho News- Roosevelt’s Partnership with Stalin
- Strategic Ambiguity (If We Must)
- Finland shreds nuclear weapons ban
- Kiev turns to ‘systematic killing’ of Zaporozhye plant staff – Russia’s nuclear chief
- Censored Lavrov article Politico refused to publish (FULL TEXT)
- Israel’s censor silenced 5,700 reports in 2025
- After US-Iran deal, Israeli minister threatens war on Syria ‘sooner or later’
- When the Iran War is over: Why the West Bank may be Netanyahu’s next front
- Israeli forces launch fresh ground incursions into Syria’s Quneitra, interrogate locals
- Syria ‘unwilling, unprepared’ to attack Lebanon despite US pressure: Report
- If Americans Knew
- What Ceasefire? Israel Has Now Killed Over 1,000 Palestinians in Gaza Since October
- U.S. Whole-of-Government Takeover by Israel
- Netanyahu’s Mouthpieces Turn on Trump, Revealing a Deeper Israeli Ingratitude
- Senate wants to force US to share sensitive intel with Israel
- Trump ended his idiotic Iran war. Good.
- Khanna Becomes First in Congress to Sign ‘Peace Pledge’ Promising to Reject AIPAC Funds
- Look who’s losing it over Trump’s Iran deal
- Israel has killed over 1,000 Gazans during 8-month “ceasefire” – Daily Update
- REVEALED: Former Top DEA Official Says Israel Spies on US Law Enforcement
- What would happen if US actually cut off military aid to Israel?
- No Tricks Zone
- New Study: Chile’s Relative Sea Level Was 3.2 Meters Higher Than Today During The Mid-Holocene
- Beyond The Pitch: Why FIFA’s World Cup Is One Of Humanity’s Best Investments
- Climate Alarmists Now Using Natural Phenomena To Support Their Claims
- New Study: Significant CO2 Fluxes From Non-Volcanic Sources Are Largely Neglected In Carbon Budgets
- Women Climate Scientists Being Harassed, Insulted By Skeptics, Claims Berkeley Earth Researcher
- Germany’s Longterm Spring Climate Data Show “No Climate Trend”
- New Study: Solar Photovoltaic, Wind Power Fail To Meet Annual Energy Demands 62% Of The Time
- Germany’s Die Welt: “Too Much Is Too Much” … Green Energies Are Cannabalizing Each Other!
- Germany’s Ecological Holocaust… Once Fairy Tale Forests Getting Cleared For Wind Turbines
- A Grand Solar Minimum Has Arrived…Global Cooling Of At Least 1°C Is Expected By The 2030s, 2040s
Aletho News 